Navigation Links
PathSensors' Ralstonia and Phytophthora Assays Validated by the USDA
Date:10/17/2018

PathSensors’ cutting-edge CANARY based assays for the detection of Ralstonia spp. and Phytophthora spp. have been validated by USDA’s Animal and Plant Health Inspection Service for use in regulatory diagnostics. By going through the validation process, users can use the assays with confidence and trust, knowing they will be able to rapidly and accurately test and identify these damaging plant pathogens.

“We’re very pleased USDA has validated this diagnostic tool,” said Ted Olsen, PathSensors President and CEO. “Ralstonia and Phytophthora are both devastating plant pathogens that cause millions of dollars in agricultural losses worldwide each year. We are excited by the problem-solving capability CANARY provides to combat these plant diseases.”

Although not considered dangerous for humans, both Ralstonia and Phytophthora can wreak havoc upon numerous crops, including fruits, vegetables, and decorative plants.

Ralstonia is a soil-borne bacteria that causes bacterial wilt which can eventually lead to plant death in a wide variety of crops, including potatoes, eggplants, tomatoes, bananas, and ornamental plants.

Phytophthora, from the Greek word for “plant destroyer,” is likewise a dangerous pathogen that causes death among many plants and crops. It is most infamously known for causing the Great Irish Potato Famine in the 1840s, but continues to have devastating effects on agriculturalists’ crops worldwide. Phytophthora is the cause of sudden oak death syndrome, which has led to significant reductions in oak populations along the Pacific coasts of California and Oregon.

PathSensors has integrated the Ralstonia and Phytophthora assays into their robust library of commercially available products. They will deploy the newly validated assays in the field to help prevent harmful plant pathogens from negatively impacting agriculture in the U.S. and abroad.

About PathSensors

PathSensors is a leading technology company providing rapid, highly sensitive, and easy-to-use pathogen detection solutions. Their CANARY technology detects a wide range of biosecurity, plant pathology, and food safety threats. PathSensors supports a growing library of threat detection capabilities that can be expanded to meet emerging requirements. CANARY technology is exclusively licensed from MIT-Lincoln Laboratory.

Read the full story at https://www.prweb.com/releases/pathsensors_ralstonia_and_phytophthora_assays_validated_by_the_usda/prweb15845867.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. GE Healthcare Translates Assays to High Content Analysis, Providing Faster Results
2. ReachBio Research Labs Offers New NK (V158+) Cells Optimized for ADCC Assays online
3. Luxcel Biosciences and HD Biosciences Enter Collaboration Agreement for Mitochondria Toxicity & Metabolism Assays for Preclinical Drug Safety Evaluation
4. Provista Diagnostics Study First to Show that Age Should Be Considered When Developing Diagnostic Assays
5. Progenetics to Distribute Biocepts Liquid Biopsy Assays in Israel
6. Canon BioMedical expands genotyping assays affecting people of Ashkenazi Jewish heritage
7. ZeptoMetrix™ (ZMC) to Release NATtrol™ Inactivated Zika Virus for the Development of Molecular Diagnostic Assays and Ongoing Clinical Laboratory Quality Control
8. Canon BioMedical expands assays to support genetic researchers
9. Cell-based Assays Market 2015 by Product, Applications, End User, & Region - Global Forecast to 2020
10. Moleculera Labs Receives Grant from OCAST to Develop Assays to Identify Individuals with Neuropsychiatric Disorders of Autoimmune Origin
11. LamdaGen Corporation Receives Notice of Allowance to Grant European Patent for Enzymatic Assays Performed on LSPR Based Plasmonic Nano-Sensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/19/2019)... Israel and BASEL, Switzerland (PRWEB) , ... ... ... Sheba Medical Center at Tel HaShomer, the largest hospital in Israel and ... develop point-of-care cell-therapy manufacturing using the state-of-the-art Cocoon™ manufacturing platform. The partnership ...
(Date:3/15/2019)... and ATLANTA (PRWEB) , ... ... ... the acquisition of 100% equity in American Process Inc. and affiliate companies ... the Alpena Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D center ...
(Date:3/14/2019)... LITTLE ROCK, Ark. (PRWEB) , ... March 14, ... ... of America’s 29th Annual Conference & Expo, themed “Navigating the Full Spectrum of ... Las Vegas, NV, June 10-14, 2019. This conference is the only case management ...
(Date:3/14/2019)... ... March 13, 2019 , ... The International Society ... , taking place in Brussels, Belgium on 25–26 September 2019. This event is ... and innovative approaches. , “Biopharmaceuticals have become a main pillar in the ...
Breaking Biology Technology:
(Date:4/9/2019)... ... April 09, 2019 , ... ... outcomes, today announced a new partnership with Ambry Genetics, a leading clinical genetic ... to state-of-the-art clinical genetic testing and family history assessment, so they may better ...
(Date:4/5/2019)... , ... April 04, 2019 , ... ... with integrated linear encoders providing 0.05 microns and 0.005 microns resolution, respectively. The ... and drive variations are available, from fast DC-servo motors with linear encoders and ...
(Date:4/4/2019)... ... April 02, 2019 , ... Orbsen ... stromal cell immunotherapies, announced it will move its base of operations from the ... the University’s newly created biotechnology park in Galway, Ireland. , “With four clinical ...
Breaking Biology News(10 mins):